Form 8-K - Current report:
SEC Accession No. 0001104659-26-032950
Filing Date
2026-03-23
Accepted
2026-03-23 06:36:25
Documents
54
Period of Report
2026-03-23
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm269553d1_8k.htm   iXBRL 8-K 41951
2 EXHIBIT 99.1 tm269553d1_ex99-1.htm EX-99.1 25603
3 EXHIBIT 99.2 tm269553d1_ex99-2.htm EX-99.2 76374
7 GRAPHIC tm269553d1_ex99-2img001.jpg GRAPHIC 96427
8 GRAPHIC tm269553d1_ex99-2img002.jpg GRAPHIC 384225
9 GRAPHIC tm269553d1_ex99-2img003.jpg GRAPHIC 138843
10 GRAPHIC tm269553d1_ex99-2img004.jpg GRAPHIC 78175
11 GRAPHIC tm269553d1_ex99-2img005.jpg GRAPHIC 205706
12 GRAPHIC tm269553d1_ex99-2img006.jpg GRAPHIC 205195
13 GRAPHIC tm269553d1_ex99-2img007.jpg GRAPHIC 111587
14 GRAPHIC tm269553d1_ex99-2img008.jpg GRAPHIC 89486
15 GRAPHIC tm269553d1_ex99-2img009.jpg GRAPHIC 144552
16 GRAPHIC tm269553d1_ex99-2img010.jpg GRAPHIC 130612
17 GRAPHIC tm269553d1_ex99-2img011.jpg GRAPHIC 141473
18 GRAPHIC tm269553d1_ex99-2img012.jpg GRAPHIC 125852
19 GRAPHIC tm269553d1_ex99-2img013.jpg GRAPHIC 72207
20 GRAPHIC tm269553d1_ex99-2img014.jpg GRAPHIC 120568
21 GRAPHIC tm269553d1_ex99-2img015.jpg GRAPHIC 130959
22 GRAPHIC tm269553d1_ex99-2img016.jpg GRAPHIC 134720
23 GRAPHIC tm269553d1_ex99-2img017.jpg GRAPHIC 139948
24 GRAPHIC tm269553d1_ex99-2img018.jpg GRAPHIC 64374
25 GRAPHIC tm269553d1_ex99-2img019.jpg GRAPHIC 121498
26 GRAPHIC tm269553d1_ex99-2img020.jpg GRAPHIC 153462
27 GRAPHIC tm269553d1_ex99-2img021.jpg GRAPHIC 376809
28 GRAPHIC tm269553d1_ex99-2img022.jpg GRAPHIC 132906
29 GRAPHIC tm269553d1_ex99-2img023.jpg GRAPHIC 132672
30 GRAPHIC tm269553d1_ex99-2img024.jpg GRAPHIC 132487
31 GRAPHIC tm269553d1_ex99-2img025.jpg GRAPHIC 130445
32 GRAPHIC tm269553d1_ex99-2img026.jpg GRAPHIC 109401
33 GRAPHIC tm269553d1_ex99-2img027.jpg GRAPHIC 171004
34 GRAPHIC tm269553d1_ex99-2img028.jpg GRAPHIC 99881
35 GRAPHIC tm269553d1_ex99-2img029.jpg GRAPHIC 82761
36 GRAPHIC tm269553d1_ex99-2img030.jpg GRAPHIC 149917
37 GRAPHIC tm269553d1_ex99-2img031.jpg GRAPHIC 191178
38 GRAPHIC tm269553d1_ex99-2img032.jpg GRAPHIC 103776
39 GRAPHIC tm269553d1_ex99-2img033.jpg GRAPHIC 143422
40 GRAPHIC tm269553d1_ex99-2img034.jpg GRAPHIC 169677
41 GRAPHIC tm269553d1_ex99-2img035.jpg GRAPHIC 93697
42 GRAPHIC tm269553d1_ex99-2img036.jpg GRAPHIC 152459
43 GRAPHIC tm269553d1_ex99-2img037.jpg GRAPHIC 115832
44 GRAPHIC tm269553d1_ex99-2img038.jpg GRAPHIC 250623
45 GRAPHIC tm269553d1_ex99-2img039.jpg GRAPHIC 227005
46 GRAPHIC tm269553d1_ex99-2img040.jpg GRAPHIC 136921
47 GRAPHIC tm269553d1_ex99-1img001.jpg GRAPHIC 3009
  Complete submission text file 0001104659-26-032950.txt   8446540

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA apge-20260323.xsd EX-101.SCH 3044
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE apge-20260323_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apge-20260323_pre.xml EX-101.PRE 22378
57 EXTRACTED XBRL INSTANCE DOCUMENT tm269553d1_8k_htm.xml XML 3343
Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Filer) CIK: 0001974640 (see all company filings)

EIN.: 934958665 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41740 | Film No.: 26779814
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)